In this study, we investigated the relationship between IHC-classified subtypes, HLA class I expression in tumor cells, CD8-positive cell infiltration into the tumor parenchyma, clinical data, progression-free survival (PFS), and overall survival (OS). Here, CD8A is linked to neoplasm.